Concomitant essential thrombocythemia with JAK2 V617F mutation in a patient with chronic myeloid leukemia with major molecular response with imatinib and long-term follow-up
Journal article published in 2016 by
Katia Borgia Barbosa Pagnano,
M�rcia Delamain,
Mariana Munari Magnus,
Jos� Vassallo 
,
Carmino Antonio De Souza ,
Daiane De Almeida,
Irene Lorand‑Metze
,
Carmino Antonio De Souza ,
Daiane De Almeida,
Irene Lorand‑Metze
This paper is made freely available by the publisher.
Full text: Download
Postprint:
archiving forbidden
Data provided by 